Centre for Innovation in Regulatory Science

14 data points extracted from 1 publication by this organisation.

Data points
14
Documents
1
Indicators
3
Regions
7
Publisher type
Research

Bibliography

Documents used

Every publication we have taken a number from, with the date we read it and the link status at that time.

Document Type Published Retrieved Link Data points
New Drug Approvals by Six Major Authorities 2016-2025 Licence: See source Press release 17 Sep 2026 Reachable 14

Every figure

Data points

Every figure taken from this organisation, grouped by indicator.

14 data points across 3 indicators.
IndicatorRegionPeriodValueTypeFull record
Common new active substance approvals across major regulatory authorities (multi-year total)Global2021–202552actual
Common new active substance approvals across major regulatory authorities (multi-year total)Global2016–202037actual
Median drug approval timeEuropean Union2025448 daysactual
Median drug approval timeAustralia2025350 daysactual
Median drug approval timeCanada2025369 daysactual
Median drug approval timeJapan2025292 daysactual
Median drug approval timeSwitzerland2025413 daysactual
Median drug approval timeUnited States2025322 daysactual
New active substance approvalsEuropean Union202539actual
New active substance approvalsAustralia202542actual
New active substance approvalsCanada202544actual
New active substance approvalsJapan202540actual
New active substance approvalsSwitzerland202534actual
New active substance approvalsUnited States202550actual

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. Credit Centre for Innovation in Regulatory Science as the original publisher; each record page carries its own citation.

Centre for Innovation in Regulatory Science. Retrieved from StatOrigin: https://statorigin.org/sources/centre-for-innovation-in-regulatory-science

Keep exploring

Related

Last verified 17 September 2026. Link status is rechecked weekly.